ECTG team

The ECTG team is headed by Peter Ponsaerts.

ECTG uses both animal models and advanced 2D/3D cell culture models of adult and pluripotent stem cells, to study and modify microglia- and macrophage-mediated immune responses in the central nervous system, focusing on multiple sclerosis and interleukin 13 as immunomodulator.